Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marlies Bahlo
Observed names:
M BAHLO,
M Bahlo,
M. Bahlo
Institution:
Universität Hamburg
Observed institutions:
Universität Hamburg,
Düsseldorf University Hospital,
University Medical Center Hamburg-Eppendorf,
Marienkrankenhaus Hamburg
OpenAlex ID:
A5110157281
CA 125 and its relation to cardiac function
1999
·
Herbert Nägele
, Marlies Bahlo
, et al.
·
American Heart Journal
·
127
CA 12-5 bei Karzinomen des Verdauungstraktes: Ein Vergleich mit CA 19-9 und CEA bei Karzinomen des Pankreas und Kolon
2008
·
R. Klapdor
, U. Klapdor
, et al.
·
DMW - Deutsche Medizinische Wochenschrift
·
29
Fluctuations of tumor markers in heart failure patients pre and post heart transplantation.
1999
·
H Nägele
, M Bahlo
, et al.
·
PubMed
·
28
CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
1999
·
D Griesenberg
, R Nürnberg
, et al.
·
PubMed
·
21
Tumor marker determination after orthotopic heart transplantation
1999
·
Herbert Nägele
, Marlies Bahlo
, et al.
·
The Journal of Heart and Lung Transplantation
·
14
TNM staging, histopathological grading, and tumor-associated antigens in patients with a history of mucoepidermoid carcinoma of the salivary glands.
1999
·
K Plambeck
, R E Friedrich
, et al.
·
PubMed
·
12
Radioimmunotherapy of Xenografts of Human Pancreatic Carcinomas - Intravenous and Intratumoral Application of 131l-Labelled Monoclonal Antibodies
1986
·
S. Lander
, M. Bahlo
, et al.
·
Nuklearmedizin - NuclearMedicine
·
12
CA19-9 serum concentrations--analysis of the serum kinetics during first-line therapy of pancreatic cancer in relation to overall survival.
2010
·
R Klapdor
, M Bahlo
, et al.
·
PubMed
·
10
P53 auto-antibodies in the sera of patients with oral squamous cell carcinoma.
1997
·
R E Friedrich
, S Bartel-Friedrich
, et al.
·
PubMed
·
10
Improvement of survival by efficacy orientated sequential polychemotherapy of exocrine pancreatic cancer.
2000
·
R Klapdor
, C Müller
, et al.
·
PubMed
·
9
Combination therapy with gemcitabine (GEM) and erlotinib (E) in exocrine pancreatic cancer under special reference to RASH and the tumour marker CA19-9.
2012
·
R Klapdor
, S Klapdor
, et al.
·
PubMed
·
8
Cytokines and pancreatic cancer
1989
·
J. -S. Kühl
, R. Klapdor
, et al.
·
International Journal of Pancreatology
·
8
Further evidence for prolongation of survival of pancreatic cancer patients by efficacy orientated sequential polychemotherapy (EOSPC) based on serial tumor marker determinations (CA 19-9/CEA).
2005
·
R Klapdor
, M Bahlo
, et al.
·
PubMed
·
6
Atypical courses of serum tumor markers--4 case reports.
2003
·
R Klapdor
, M Bahlo
, et al.
·
PubMed
·
6
Sequential polychemotherapy in exocrine pancreatic cancer.
2003
·
R Klapdor
, M Bahlo
, et al.
·
PubMed
·
6
Combined Therapy of Xenografts of Human Pancreatic Carcinomas With rTNF-α and Mitomycin C
2009
·
R. Klapdor
, N. Franke
, et al.
·
Onkologie
·
5
Reflections on treatment strategies for palliative chemotherapy of pancreatic cancer.
2007
·
R Klapdor
, M Bahlo
, et al.
·
PubMed
·
3
Effects of cytotoxic drugs on tumor marker secretion of gastrointestinal/pancreatic carcinomas--comparison of studies in nude mice and in patients.
1989
·
U Klapdor
, R Klapdor
, et al.
·
PubMed
·
2
Immunoscintigraphy with Combinations of Various Monoclonal Antibodies – Studies on Xenografts of Human Gastrointestinal Carcinomas
1988
·
U. Horstmeier
, M. Bahlo
, et al.
·
Nuklearmedizin - NuclearMedicine
·
2
Tumor marker secretion (CA 19-9, CEA, CA 125) by xenografts of eight different human pancreatic carcinomas compared to the human tumors.
1989
·
R Klapdor
, F Harms
, et al.
·
PubMed
·
1
Effects of MAb BW 494/32 and rTNF-a/rIFN-g alone and in combination in nude mice bearing xenografts of human gastrointestinal/pancreatic carcinomas.
1989
·
R Klapdor
, O Schwarzenberg
, et al.
·
PubMed
·
1
Transplantation of Exocrine Pancreatic Carcinomas to Nude Mice
2015
·
R. Klapdor
, M. Bahlo
, et al.
·
KARGER eBooks
Hypokalemia associated with partial paralysis due to thyrotoxicosis
2006
·
T Wertenbruch
, H Willenberg
, et al.
·
Experimental and Clinical Endocrinology & Diabetes
510 Inhibition of cyclooxygenase-2 suppresses the growth of human hepatocellular carcinoma implants in vivo
2003
·
M KERN
, M SCHONEWEISS
, et al.
·
Hepatology
Clinical evaluation of the chiron diagnostics ACS GI assay A comparison study with other tests for the detection of CA 19-9 antigen
1997
·
C. Fenner
, M Bahlo
, et al.
·
Anticancer Research
Show more works
View as search
Works count:
29
Citation count:
320
H-index:
9
I10-index:
9
Year
Topic
Type
